Today PositiveID Corporation ($PSID) continued its incredibly active month by announcing that it expects to give a much more efficient way of detecting lower quantities of organisms present in subjects who are being tested for pathogens. PSID, which recently acquired Thermomedics Inc , has developed the new Firefly Dx prototype system which now includes PCR capabilities. This market is expected to reach over $27.4 billion this year alone. This arguably puts PSID in a very good spot, as it’s Firefly device can provide accurate diagnostic results in less than 20 minutes – all from a handheld device.

While the news of the acquisition, and the latest information about Firefly is stimulating, and has been attracting the attention of a lot of investors – it’s current activity is truly impressive. Where some businesses will lay dark for weeks or months at a time before making any announcements, PSID has managed to stay incredibly active, releasing pertinent and informative insights every few days. This much growth and eagerness to keep the public informed about its potentially life changing technology is what is truly driving investor awareness for the company.

Over the last couple weeks’ accumulation of shares has been on the rise, according to some stock chart analysis. The share price continues to fluctuate, but is trending upwards, and volume has been growing as well showing that the company is attracting investors. Furthermore, other indicators are pointing towards more growth over the coming weeks. While this is all speculative, the multitudes of data in agreement is probably causing even more investors to put PSID on their watch lists.

Keep your eyes on the PSID as they continue to release new information for their latest technologies and move towards their test unit release of 4th quarter 2016.